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Abstract Allergic rhinitis, nonallergic rhinitis, and chronic
rhinosinusitis are multifactorial upper airway diseases with
high prevalence. Several genetic and environmental factors
are proposed to predispose to the pathogenesis of the inflam-
matory upper airway diseases. Still, the molecular mecha-
nisms leading toward the onset and progression of upper
airway diseases are largely unknown. The upper airway epi-
thelium has an important role in sensing the environment and
regulating the inhaled air. As such, it links environmental
insults to the host immunity. Human sinonasal epithelium
serves as an excellent target for observing induced early-
phase events, in vivo, and with a systems biological perspec-
tive. Actually, increasing number of investigations have pro-
vided evidence that altered homeostasis in the sinonasal epi-
thelium might be important in the chronic upper airway
inflammation.
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Introduction
Allergic rhinitis (AR), nonallergic rhinitis (NAR), and chronic
rhinosinusitis (CRS) are multifactorial chronic inflammatory
upper airway diseases with high prevalence and large variation
in their characters. The diseases are affected by each other, by
lower airway diseases, by the composition of inhaled air, infec-
tions, the sensitization profile, and many genetic and lifestyle-
related factors [1–6]. Allergic rhinitis (AR) is an IgE-mediated
symptomatic inflammation with a prevalence of 10–20 % in
worldwide population [1]. In tropical urban environment, the
major cause for AR is mite monosensitization, whereas in other
climate zones, multiple sensitizations to several allergen types
predominate [7, 8]. Nonallergic noninfectious rhinitis (NAR)
has variable etiology and a prevalence of 5–10%worldwide [9,
10]. The etiology underlies local allergic rhinitis, hormonal, and
medication-induced conditions, among others [9–11]. A sub-
group of patients with NAR has fluctuating nasal hyperreactiv-
ity induced by many irritants and temperature changes without
a defined etiology. Its mechanism might be related to a dys-
function of autonomous nervous system [12]. Chronic
rhinosinusitis (CRS) is a chronic symptomatic inflammation
of the sinonasal tract, with prevalence around 10 % [13]. CRS
presents with or without nasal polyps (NP). Patients with
nonsteroidal anti-inflammatory drug (NSAID)-exacerbated re-
spiratory disease (e.g., NERD) tend to have more severe forms
of CRS with nasal polyps and asthma.
The pathomechanisms of inflammatory airway diseases are
connected to the large biological networks between the envi-
ronment and the host. During development, host genetics and
environmental factors can significantly modulate the barrier
homeostasis, thus influencing the predilection toward chronic
inflammation of the airways. The respiratory epithelium has
important innate immunity functions. It also mediates parts of
the innate and adaptive immunity by its antigen presentation,
phagocytosis, and pattern recognition abilities. Thus, altered
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airway barrier functions might have a pivotal role in the
pathogenesis of chronic airway inflammation. Human nasal
epithelium and secretions are easily accessible. Thus, they
provide an excellent target for systems level studies on in-
flammation [88]. This is possible particularly in patients with
seasonal rhinitis because the triggering factors can be identi-
fied [14, 15]. It has been suggested that investigations on nasal
epithelial interactions might provide additional knowledge for
the lower airway inflammation [16]. Of note, nerve endings
and immune cells might be fundamental in response to mul-
tiple environmental factors [14, 17, 18]. However, in this
review, the authors mainly focus on the biology of human
upper airway epithelium in AR, NAR, and CRS.
Genomics of the Upper Airway Diseases with Epithelial
Context
There is a clear hereditary component in allergic rhinitis that
has been well corroborated by segregation studies and investi-
gations in twins [19, 20]. However, much less evidence exists
on inheritage of NAR [21] and of CRS [22]. Genome-wide
association studies (GWAS) have reported 22 significant AR-
associating loci [23, 24, 25•, 26•, 27]. Based on our unpub-
lished results of RNA-sequencing for nasal brushings, less than
half of these loci could have epithelial function. Yet, their role
in the epithelium and other cell types during the development
of AR has not been resolved. As an example, FOXA1 (25) is
connected to cell differentiation. It can increase the expression
of mucin 2 gene in goblet cells [28]. TPD52 [25•] is expressed
predominantly by epithelial cells and has a function in the
development or maintenance of the epithelial cell phenotype,
in cell proliferation, migration, and cell death [29]. ID2 [25•]
binds TGF-β and takes part in cell differentiation, apoptosis,
and epithelial to mesenchymal transition [30]. IL4R [25•] has a
role in the regeneration and in enhancing MUC4 in respiratory
epithelium. It binds IL4 and IL13, which promote IgE produc-
tion and differentiation of Th2 cells [31]. ETS1 [25•] is a
transcription factor particularly expressed in basal cells of
airway epithelium. It is important in stem cell development,
cell senescence, and death [32]. TLR1-TLR6-TLR10 [25•] and
NOD1 [23] are pattern recognition receptors found in nasal
epithelium [33]. Interestingly, Nilsson et al. performed a repli-
cation study in children with AR and showed that TLR6-TLR1
locus is likely to have a central role in the development of
allergic disease [34]. Still, further studies are needed to show,
whether these AR-associating loci are important in epithelial
pathology during airway allergy.
Bunyavanich et al. studied further the biologic context for
AR-associating loci identified by GWAS, by expression quan-
titative trait loci (eQTL) and expression single nucleotide
polymorphism (eSNP) mapping, as well as by network and
pathway analyses [26•]. Interestingly, they recognized
enrichment in mitochondrial pathways [26•]. Previous studies
have detected the mitochondrial dysfunction of airway epithe-
lium during bacterial and viral infections, cigarette smoking,
and asthma [35].
Two pooling-based GWASes are known for the CRS phe-
notype. A study discovered three loci that consistently associ-
ate with CRS, yet their function in sinonasal epithelium is not
confirmed: TCF7L2 [36] participates in the Wnt signaling
pathway and modulates MYC expression. It maintains the
epithelial stem cell compartment of the small intestine.
AOAH [36] has been replicated significantly in a Chinese
population [37]. It is expressed in epithelium and leukocytes.
It detoxifies gram-negative bacteria by hydrolyzing
acyloxylacyl-linked fatty acyl chains of lipopolysaccharides.
TP73 [38] mediates oxidative stress response, cell differentia-
tion, and remodeling in nasal polyp epithelium [39]. The group
of Desrosiers performed also RNA array analysis and detected
upregulation of the expression of the LAMB1 gene and the
laminin pathway, in differentiated primary epithelial cells from
CRS patients, suggesting a role for extracellular matrix genes
in the development of CRS [40]. To the knowledge of the
authors, there are no GWAS studies on NAR phenotypes.
The Interplay Between Inhaled Particles and Epithelial
Transcriptome
A great variety of allergen-, host-, and environment-
dependent mechanisms facilitates allergen and pathogen
entry into the respiratory mucosa. Allergens have pro-
teolytic, lipid-binding, and microbial-mimicking proper-
ties which enable their entry [41]. Penetration of mite
allergens, for instance, associates with aberrant host
functions such as pattern recognition, calcium metabo-
lism, and cell-cell contacts [42, 43•, 44, 45]. We have
demonstrated by electron microscopy and proteomics
that birch pollen allergens (Bet v1) were able to bind
plasma membrane lipid rafts and were rapidly
transported through the epithelium in caveolar vesicles
to meet a mast cell solely in patients allergic to birch
[46]. Microarray experiments have shown that pollen
exposure causes greatest fold changes in the nasal
epithelial transcripts that belong to immunology cate-
gory in controls, whereas response to virus and cellular
transportation are abundant categories in pollen allergic
subjects [15, 47].
We performed RNA microarray of cultured epithelial cells
from bronchial brushings and nasal biopsies and showed that
about 2000 genes were differentially expressed between
healthy lower and upper airway epithelium, whereas in aller-
gic rhinitis with or without asthma, this was only 40 and 301
genes, respectively. Genes influenced by allergic rhinitis with
or without asthma were linked to lung development, remod-
eling, regulation of peptidases, and normal epithelial barrier
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functions [48]. We also stimulated primary nasal and bronchi-
al epithelial cells from the same individuals by a viral double-
stranded RNA (dsRNA) analog poly (I:C) and identified gene
expression profiles by RNA-array analysis. Asthma patients
demonstrated significantly fewer induced genes, exhibiting
reduced downregulation of mitochondrial genes. The majority
of genes related to viral responses appeared to be similarly
induced in upper and lower airways in all groups. However,
the induction of several interferon-related genes was impaired
in patients with asthma [48]. Interestingly, expression profil-
ing showed resemblance in the cytokine profiles of EGR1,
DUSP1, FOSL1, JUN, MYC, and IL6 after stimulation of
airway epithelial cells with either dsRNA or with house dust
mite; however, both triggers also induced a specific response
(e.g., ATF3, FOS, and NFKB1) [49•]. This and other studies
suggest that the risk for microbial infection and its underlying
immune dysfunction might be a phenotypic or clinical feature
of both atopic and nonatopic chronic conditions in the airways
than only a secondary effect [5].
Modulation of Transcriptome in Upper Airway Epithelium
There are several molecular mechanisms by which en-
vironmental factors might regulate gene expression.
Epigenetic mechanisms alter gene expression without
altering the underlying DNA sequence [50]. The most
studied epigenetic mechanisms are DNA methylation
and histone modifications. Early infections together with
other factors may shape developing immunity via epi-
genetic programming, which is partly inherited [51, 52].
Buro-Auriemma et al. showed that cigarette smoking
induces small airway epithelial epigenetic changes with
corresponding modulation of gene expression [53]. So
far, epithelial epigenetics in upper airways have not
been studied on systems level.
Recent genome-wide studies confirm that much of
the DNA that does not encode proteins encode various
types of functional RNAs, which are important players
in gene regulation. MicroRNAs (miRNA) are small
noncoding RNAs and important fine tuners of immune
systems [54]. By binding to its target transcripts,
miRNA is able to decrease translation [54]. Rager per-
formed RT-PCR on nasal epithelial samples from ma-
caques that inhaled formaldehyde and detected signifi-
cant modification in miRNA expression profiles, which
influence apoptosis signaling [55]. McKiernan examined
long noncoding RNA transcripts (lncRNAs) from bron-
chial brushings by microarray analysis and found that
1063 out of over 30,000 lncRNAs had different expres-
sion between cystic fibrosis and noncystic fibrosis indi-
viduals [56]. Thus, it seems that pathologic processes in
the airway epithelium are partly driven by noncoding
RNAs, which might alter the regulation of gene
expression.
Disrupted Epithelium During Chronic Upper Airway
Diseases
Airway epithelium has important functions that mediate in-
nate immunity actions, maintain cell integrity, and promote
self-renewal. These functions seem to be essentially involved
in the development of human chronic upper airway disorders.
Mucociliary Clearance
Cilia are microtubule-based hair-like organelles that play
many important roles in development and physiology, and
they are implicated in a rapidly expanding spectrum of human
diseases, collectively termed ciliopathies. Mucociliary clear-
ance (MCC) is crucial in defense against inhaled insults.
Coordinated ciliary beating transports debris-laden mucus
from respiratory passages toward the oropharynx [57].
Primary ciliary dyskinesia (PCD) is a congenital ciliopathy
with complexity in genetics. Choksi et al. performed whole-
transcriptome microarray on zebrafish cilia model. After
Foxj1 induction, the corresponding proteins of the modified
transcripts are required for ciliary motility and ciliogenesis,
such as tubulin-modifying enzymes, components of the tran-
sition zone, and intraflagellar transport [58]. Moreover, they
performed PANTHER protein characterization and identified
cytoskeletal proteins that could serve as structural components
of cilia (78 genes), possible regulators of ciliary differentiation
and function, including transcriptional regulators (26 genes)
and protein regulators such as kinases (19 genes), phospha-
tases (8 genes), and enzyme modulators (61 genes), suggest-
ing that motile cilia may perform more sensory and signaling
functions than previously recognized.
Patients suffering from PCD have typically recurrent and
prolonged bacterial infections in the airways, chronic
rhinosinusitis with nasal polyps, and chronic alterations in
the middle ear and lower airways. It implicates the importance
of ciliary function in preventing infections and chronic airway
inflammation. Ciliary beating frequency increases in response
to multiple host and environmental stimuli through several
second messenger pathways including intracellular Ca2+ and
NO production [57]. A bitter taste receptor, T2R38, is
expressed in human upper respiratory epithelium and is acti-
vated in response to acyl-homoserine lactone quorum-sensing
molecules secreted by gram-negative bacteria such as
Pseudomonas aeruginosa. Receptor activation regulates
calcium-dependent NO production, resulting in stimulation
of mucociliary clearance and direct antibacterial effects.
T2R38 taste receptor polymorphism associated with
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susceptibility to human sinonasal gram-negative bacterial in-
fection [59]. Li et al. have been successful in the culture of
human nasal epithelial cells derived from stem cells which are
isolated from nasal biopsies in patients with CRSwNP and
without PCD diagnosis. They found a significant association
of aberrant ciliogenesis with primary motile cilia impairment,
that is more frequent in patients with CRSwNP than previ-
ously thought [60•]. Prostaglandin E2 (PGE2) has shown to
be important for normal mucociliary function in vitro and in
animal models [61, 62]. PGE2 synthase knockout mice have
prostaglandin E2 deficiency which leads to a phenotype of
aspirin sensitivity [63].
Ion Channels and Mucus
Cilia are coatedwithmembrane-spanningmucins and tethered
mucopolysaccharides that exclude mucus from the periciliary
space and promote formation of distinct mucus layer [64].
Secretory cells produce a different class of mucins, the poly-
meric gel-forming mucins. The two major airway gel-forming
mucins are MUC5AC and MUC5B. Some secretory cells,
known as mucous or goblet cells, produce mucins and store
them within easily visualized collections of mucin granules,
whereas other cells produce and secrete mucins (especially
MUC5B) but lack prominent granules. Gel-forming mucins
are secreted into the airway lumen and are responsible for the
characteristic viscoelastic properties of the mucus gel layer
[65]. Cystic fibrosis (CF) is a lethal multisystem, autosomal
recessive disorder. Over 1900 mutations have been identified
in the cystic fibrosis transmembrane conductance regulator
(CFTR) gene, which encodes anATP-regulated chloride chan-
nel and is present within the apical surface of epithelial cells
[56]. The respiratory characters of CF are decreased airway
surface liquid volume, increased mucus viscosity, pathogen
colonization, impaired protease-antiprotease balance, pulmo-
nary inflammation, and CRSwNP, yet the pathomechanisms
are not fully understood [56].
Birket et al. performedmicrooptical coherence tomography
on wild-type and CF piglet trachea and demonstrated a direct
link between periciliary liquid (PCL) hydration and
mucociliary transport (MCT) rates, a relationship frequently
invoked but never experimentally confirmed. However, in CF
airways, this relationship was completely disrupted, with
greater PCL depths associated with slowest transport rates.
This disrupted relationship was recapitulated by selectively
inhibiting bicarbonate transport in vitro and ex vivo. CF
mucus exhibited increased viscosity in situ due to the absence
of bicarbonate transport, explaining defective MCT that oc-
curs even without infection, inflammation, or aberrant PCL
hydration [66]. Vasoactive intestinal peptide (VIP) is a neuro-
transmitter that has been shown to increase the ciliary beat
frequency and CF transmembrane conductance regulator-
dependent fluid secretion. The detected upregulation of VIP
in allergy could contribute to allergic rhinorrhea whereas a
loss of VIP-activated secretion in patients with CFmay impair
mucociliary transport, contributing to increased incidences of
sinonasal infections and rhinosinusitis [59]. Apical potassium
channels regulate ion transport in airway epithelial cells and
influence air surface liquid hydration and mucociliary clear-
ance. Two airway epithelial potassium channels have been
discovered as susceptibility loci associating to pediatric CRS
[67]. Studies are still needed to evaluate the function of
potassium channels in CRS pathogenesis. The allergic rhinitis
mucus proteome showed a decrease in antiprotease activity
which could affect the epithelial barrier during the insult of
allergen proteases [68].
Antimicrobial Proteins and Immunoglobulin A
Both mucosal and glandular epithelial secrete a large array of
molecules that are known to kill or neutralize microorganisms.
Disruption of this antimicrobial action might lead to the risk of
colonization or infection by microorganisms, which might
associate to pathogenesis chronic airway inflammation.
Epithelial host defense molecules include small peptides that
lyse bacteria and enzymes. Lysozyme targets glycosidic bonds
in the peptidoglycan cell wall of bacteria, typically leading to
an enzymatic lysis, and is highly effective against many
common upper airway gram-positive bacteria, such as strep-
tococci [69]. Lactoferrin sequesters iron, leading to the inhi-
bition of bacterial growth. Secretory leukocyte proteinase
inhibitor kills both gram-positive and gram-negative bacteria.
Defensins are small cysteine-rich cationic proteins that are
directly toxic to many bacteria, fungi, and viruses. They form
pore-like structures in microbial membranes leading to efflux
of essential ions and nutrients [69]. The S100 proteins com-
prise a multigene family consisting of more than 20 low-
molecular weight proteins that have numerous effects, includ-
ing influences on cell differentiation and transformation, bar-
rier function, and direct antimicrobial actions. S100A7 kills
Escherichia coli and is reduced in nasal fluid during allergic
rhinitis [69]. S100A7 and S100A8/S100A9 is reduced in both
patients with CRSsNP and CRSwNP [69].
SPINK5 is a serine protease inhibitor regulating proteases
that might compromise barrier [70]. Highly reduced expres-
sion of SPINK has been observed in the epithelial cells taken
from patients with CRS. Decrease in the number of glands in
nasal polyps of patients with CRSwNPmay lead to a localized
defect in the production of antimicrobial proteins such as
lactoferrin, lysozyme, and proteins of the PLUNC family
[71]. Wei et al. performed immunohistochemistry, qRT-PCR,
Western blot, and ELISA and demonstrated reduced antimi-
crobial SPLUNC1 expression and numbers of submucosal
glands in the eosinophilic CRSwNP subset compared with
the noneosinophilic subset. Moreover, SPLUNC1 expression
in polyp epithelial cells was significantly inhibited by IL-4
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and IL-13 stimulation in vitro but was significantly upregu-
lated after stimulation with toll-like receptor agonists and
glucocorticoids [72]. Epithelial polymeric Ig receptor expres-
sion is decreased in patients with CRSwNP and AR, which
results in decreased secretory component and IgA antibodies
in nasal secretions in parallel to subepithelial accumulation of
IgA. This defect in mucosal immunity was associated with
eosinophilic, Th2-related inflammation [73].
Pattern Recognition Receptors
Toll-like receptors (TLR1-TLR10), RIG-like receptors and
dectins are among the most known pattern recognition mole-
cules. When they get into contact with the environment, they
rapidly detect microbe-associated molecular patterns and ei-
ther maintain homoeostasis or induce immune responses.
Lipopolysaccharide (LPS) of gram-negative bacteria is a mo-
lecular pattern recognized by the host through the transmem-
brane TLR4 and myeloid differentiation antigen (MD-2).
Animal models from the lower airways showed that house
dust mite allergen, Der p 2, is an MD-2 analog. By binding
LPS and epithelial TLR4, Der p 2 may activate pro-
inflammatory signaling and stimulate IgE production and
allergic reaction [74]. Fransson et al. demonstrated mRNA
and protein expression of TLRs 2, 3, and 4 in the nasal mucosa
both in subjects with and without birch and/or timothy pollen
allergy [75].
Tengroth et al. demonstrated by RTq-PCR immunohisto-
chemistry and flow cytometry that nasal apical epithelium
expresses abundantly TLR3, TLR7, TLR9, RIG-I, and
MDA-5. Moreover, they showed by ELISA upregulated cy-
tokines (IL-6, GMCSF, IL-8, IFN-b) in the nasal mucosa after
stimulation of several TLR agonists, which suggests that
epithelial TLR and RLR receptors might mediate nasal viral
response and thus could be important in exacerbations [76•].
The group also analyzed by flow cytometry and Luminex
naïve nasal polyp and turbinate tissues as well as human
tissues after in vivo and in vitro stimulation with a TLR9
agonist, CpG. Interestingly, epithelial expression of TLR9
was detected in turbinates from healthy controls and in polyp
tissue, whereas TLR9 was absent in turbinates from CRSwNP
patients. CpG stimulation resulted in an upregulation of TLR9
and modulation of cytokines in turbinate tissue from patients,
suggesting that defects in the TLR9-mediated microbial de-
fense in the turbinate might explain virus-induced polyp
growth [77].
Signaling and Protein Synthesis
Upper airway epithelium secretes several cytokines including
TSLP, IL33, and IL-25. These cytokines are released by tissue
damage, pathogen recognition, or allergen exposure. They
effect on Th2 cell function either directly or via innate
lymphoid cells, which in turn produce IL-5, IL-9, and IL-13
[14, 78]. These mechanisms are relevant to both human
CRSwNP and asthma [17, 79, 80]. Their relevance to allergic
rhinitis is also under investigation. TSLP production by hu-
man nasal epithelial cells in vitro was stimulated by a TLR2
ligand as well as by IL-1β and TNFα. Both reduced and
increased expression of IL-33 gene or protein has been de-
tected in nasal epithelium from patients with allergic rhinitis.
Asthma-associated gene, ORMDL3, is involved in regulating
endoplasmic reticulum (ER) stress responses and ER-
mediated calcium signaling [65, 81]. In addition, Orm proteins
form complexes with serine palmitoyl-CoA transferase (SPT),
the first and rate-limiting enzyme in sphingolipid production,
and might thereby help coordinate lipid metabolism in the
secretory pathway [82]. Mucins travel from the ER to the
Golgi where they are O-glycosylated multimerized and
packed, before being secreted by exocytosis [65]. Whether
epithelial ER functions and mucin production play a role in
the development of chronic upper airway diseases needs to be
proven.
Intercellular Junctions
Inhaled air particles can disrupt barrier integrity, which
might represent a risk factor for allergen sensitization
and infections [42]. Tight junctions (TJs) consist
claudins and occludins. TJs are located most apically
and inhibit solute and water flow through the
paracellular space, thus establishing cell polarity. They
link to the actin cytoskeleton. Epithelium membrane
protein 1 (EMP1) is a tight junction protein which
might mediate cell proliferation [83]. The levels of
EMP1 mRNA and immunostaining were lower in nasal
polyp epithelium compared to control nasal mucosa.
Corticosteroid treatment and mild histological findings
increased the mRNA levels indicating putatively epithe-
lial healing [83]. Soyka et al. detected a decreased
trans-tissue resistance in biopsy specimens from patients
with CRSwNP along with decreased TJ proteins
occludin and zonula occluden expression by immunoflu-
orescence, Western blotting, and RTq-PCR [84].
Adherens junctions (AJs) are located below the TJs in
the lateral membrane. AJs are especially important for
the maintenance of cell-cell adhesion and are comprised
of the cadherin and nectin families. In epithelial cells,
E-cadherin binds to intracellular catenins, thus linking
AJs with the signaling system from outside to the inside
of the cell. This evolutionarily conserved pathway reg-
ulates gene expression and chromatin structure implicat-
ed in epithelial wound repair responses and differentia-
tion. Sustained loss of E-cadherin leads to epithelial-
mesenchymal transition (EMT) [42].
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Self-Renewal
Nasal epithelial repair and remodeling is a highly orga-
nized process leading to necessary self-renewal after
injury [85]. The normal upper airway epithelium com-
prises ciliated cells (representing 50–90 % of cells),
mucus-secreting goblet cells, and basal cells (6–30 %)
which are considered as stem cells [86•]. Both epithelial
specification and terminal differentiation are critical to
epithelial homeostasis. Upon injury, nondifferentiated
basal cells migrate and proliferate into ciliated and
goblet cells in injured regions. Moreover, epithelial cells
may dedifferentiate through squamous metaplasia or ep-
ithelial to mesenchymal transition (EMT), which de-
scribes a rapid and normally reversible modulation of
the epithelial phenotype toward mesenchymal cells
[86•]. Epithelial cells undergoing EMT lose cell-cell
polarity and adhesion to become migratory and usually
downregulate junctional proteins (such as E-cadherin)
while modulating their cytoskeleton organization and
acquiring mesenchymal features such as alpha-smooth
muscle actin (SMA), vimentin, matrix metalloprotein-
ases (MMPs), and the transcription factors SNAIL,
SLUG, and TWIST [86•, 87]. Aberrant repair leads to
basal-cell and goblet-cell hyperplasia and has been
found in chronic upper airway diseases [85]. De Borja
Callejas et al. performed electron microscopy, immuno-
cytochemistry, ELISA, and cytometric bead array for
primary nasal epithelial cells that were cultured in an
air-liquid interface. They detected that β-tubulin IV- and
MUC5AC-positive cells increased and ΔNp63-positive
cells decreased, indicating re-differentiation. They also
found that when being fully differentiated, nasal polyp
epithelium secreted more IL-8 and GMCSF than control
epithelia [88]. Hupin et al. showed by immunohisto-
chemistry and RT-qPCR a reduction of E-cadherin, high
molecular weight CKs, and CK5 in CRSwNP and/or
CRSsNP. This epithelial reprogramming correlates with
subepithelial fibrosis and with disease severity and was
not due to changes in lineage specification [86•].
The proprotein convertases (PCs) are serine proteases
responsible for the proteolytic maturation of many pre-
cursor proteins involved in upper airway remodeling.
PC1/3 overexpression induces in vitro morphological
and phenotypic epithelial-mesenchymal transition chang-
es of airway epithelial cells and putatively contributing
to the pathogenesis of nasal polyps [87]. Host cell
metabolism is manipulated by viruses for their replica-
tion and is usually followed by host cell destruction.
However, early cell death, by apoptosis, can reduce
virus replication and is an important factor in augment-
ing antigen presentation and host immune response [85].
Jeffe et al. showed in nasal tissue and cultured cells by
PCR, immunohistochemistry, Western blotting, and im-
munofluorescence that BP180, a critical anchoring pro-
tein in keratinocytes, is widely expressed in nasal epi-
thelium. Nonpathologic anti-BP180 antibodies were ele-
vated in sera from CRS patients, although the authors
conclude that this association may be linked to atopy
[89]. Significantly higher levels of anti-dsDNA antibod-
ies have been shown to correlate with recurrent nasal
polyps requiring revision surgery [90]. Further evidence
is needed to establish the role of autoimmune response
in the pathogenesis of CRS.
Conclusions and Future Needs
Sinonasal tissues are available and environmental effects
can be induced in vivo, which allows performing high-
quality experiments in human. There is a high need to
study which epithelial mechanisms are crucial in the
development of the disease and which are consequen-
tial? Systems biology approach is essential in the search
for the upstream events of chronic upper airway dis-
eases on the pathway level. An important goal in the
future would be to study the biological network between
environment, airway epithelium, and immune and ner-
vous systems as a whole. In order to get a more
comprehensive picture, better phenotyping and usage
of endotypes of the disease would be mandatory. For
instance, sensitization to multiple allergens seems to
associate with a more severe phenotype in certain pop-
ulations, thus atopy or allergic rhinitis seems not to be a
dichotomous value, not to mention the challenges of
phenotyping NAR or CRS [3, 91]. The development
of functional proteomics and lipidomics, as well as that
of sequencing and computational methods, will improve
our ability to customize patient-specific strategies to
prevent, to detect, and to treat the chronic upper airway
diseases.
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